124 related articles for article (PubMed ID: 2548535)
1. Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV.
Evans LA; Thomson-Honnebier G; Steimer K; Paoletti E; Perkus ME; Hollander H; Levy JA
AIDS; 1989 May; 3(5):273-6. PubMed ID: 2548535
[TBL] [Abstract][Full Text] [Related]
2. Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera.
Koup RA; Sullivan JL; Levine PH; Brewster F; Mahr A; Mazzara G; McKenzie S; Panicali D
J Virol; 1989 Feb; 63(2):584-90. PubMed ID: 2536094
[TBL] [Abstract][Full Text] [Related]
3. Patterns of antibody recognition of selected conserved amino acid sequences from the HIV envelope in sera from different stages of HIV infection.
Shafferman A; Lennox J; Grosfeld H; Sadoff J; Redfield RR; Burke DS
AIDS Res Hum Retroviruses; 1989 Feb; 5(1):33-9. PubMed ID: 2541748
[TBL] [Abstract][Full Text] [Related]
4. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
Lyerly HK; Reed DL; Matthews TJ; Langlois AJ; Ahearne PA; Petteway SR; Weinhold KJ
AIDS Res Hum Retroviruses; 1987; 3(4):409-22. PubMed ID: 2833917
[TBL] [Abstract][Full Text] [Related]
5. Broadly reactive antibody-dependent cellular cytotoxic response to HIV-1 envelope glycoproteins precedes broad neutralizing response in human infection.
Koup RA; Pikora CA; Mazzara G; Panicali D; Sullivan JL
Viral Immunol; 1991; 4(4):215-23. PubMed ID: 1726398
[TBL] [Abstract][Full Text] [Related]
6. GP120 specific cellular cytotoxicity in HIV-1 seropositive individuals. Evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibody.
Tyler DS; Nastala CL; Stanley SD; Matthews TJ; Lyerly HK; Bolognesi DP; Weinhold KJ
J Immunol; 1989 Feb; 142(4):1177-82. PubMed ID: 2536767
[TBL] [Abstract][Full Text] [Related]
7. Early detection of antibodies against rDNA-produced HIV proteins with a flow cytometric assay.
Scillian JJ; McHugh TM; Busch MP; Tam M; Fulwyler MJ; Chien DY; Vyas GN
Blood; 1989 May; 73(7):2041-8. PubMed ID: 2540862
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal antibody against glycoproteins of human immunodeficiency virus.
Sugano T; Masuho Y; Matsumoto Y; Lake D; Gschwind C; Petersen EA; Hersh EM
Biochem Biophys Res Commun; 1988 Sep; 155(3):1105-12. PubMed ID: 2845963
[TBL] [Abstract][Full Text] [Related]
9. Failure of ADCC to predict HIV-associated disease progression or outcome in a haemophiliac cohort.
Dalgleish A; Sinclair A; Steel M; Beatson D; Ludlam C; Habeshaw J
Clin Exp Immunol; 1990 Jul; 81(1):5-10. PubMed ID: 2379323
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent cellular cytotoxicity directed against cells expressing human immunodeficiency virus type 1 envelope of primary or laboratory-adapted strains by human and chimpanzee monoclonal antibodies of different epitope specificities.
Alsmadi O; Tilley SA
J Virol; 1998 Jan; 72(1):286-93. PubMed ID: 9420226
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance.
Allain JP; Laurian Y; Einstein MH; Braun BP; Delaney SR; Stephens JE; Daluga CK; Dahlen SJ; Knigge KM
Blood; 1991 Mar; 77(5):1118-23. PubMed ID: 1671648
[TBL] [Abstract][Full Text] [Related]
12. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
Front Immunol; 2018; 9():244. PubMed ID: 29651286
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain.
Till MA; Zolla-Pazner S; Gorny MK; Patton JS; Uhr JW; Vitetta ES
Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1987-91. PubMed ID: 2538826
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro.
Krowka JF; Stites DP; Jain S; Steimer KS; George-Nascimento C; Gyenes A; Barr PJ; Hollander H; Moss AR; Homsy JM
J Clin Invest; 1989 Apr; 83(4):1198-203. PubMed ID: 2703528
[TBL] [Abstract][Full Text] [Related]
15. Partial purification of native HIV transmembrane protein gp41: generation of polyclonal and monoclonal antibodies.
Zweig M; Showalter SD; Bladen SV; Gilden RV; Arthur LO; Robey WG; Nara PL; Fischinger PJ
AIDS Res Hum Retroviruses; 1988 Feb; 4(1):51-62. PubMed ID: 3259140
[TBL] [Abstract][Full Text] [Related]
16. Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals.
Weinhold KJ; Lyerly HK; Matthews TJ; Tyler DS; Ahearne PM; Stine KC; Langlois AJ; Durack DT; Bolognesi DP
Lancet; 1988 Apr; 1(8591):902-5. PubMed ID: 2895830
[TBL] [Abstract][Full Text] [Related]
17. Humoral response to oligomeric human immunodeficiency virus type 1 envelope protein.
Richardson TM; Stryjewski BL; Broder CC; Hoxie JA; Mascola JR; Earl PL; Doms RW
J Virol; 1996 Feb; 70(2):753-62. PubMed ID: 8551612
[TBL] [Abstract][Full Text] [Related]
18. Use of synthetic oligopeptides in identification and characterization of immunological functions in the amino acid sequence of the envelope protein of HIV-1.
Modrow S; Höflacher B; Mellert W; Erfle V; Wahren B; Wolf H
J Acquir Immune Defic Syndr (1988); 1989; 2(1):21-7. PubMed ID: 2537398
[TBL] [Abstract][Full Text] [Related]
19. Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160.
Berman PW; Riddle L; Nakamura G; Haffar OK; Nunes WM; Skehel P; Byrn R; Groopman J; Matthews T; Gregory T
J Virol; 1989 Aug; 63(8):3489-98. PubMed ID: 2545918
[TBL] [Abstract][Full Text] [Related]
20. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
Neurath AR; Strick N; Lee ES
J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
